JC: TICH TICH BOOM? TXA in ICH. St Emlyn’s
TXA. Huh. Good god y’all. What is it good for? Absolutely everything. This appears to be the alternative hypothesis for the TICH-2 study 1, published last week in the Lancet. …
CAP37
Who gets a Tetanus? You get a Tetanus!
UPDATE – This post still contains relevant information about tetanus, immunisation schedules, and management of clinical tetanus, however the UK guidelines have changed. Please continue to read this post, but …
JC: Kicking against the prick: Systematic Review of stroke thrombolysis
I think it’s probably fair to say that stroke physicians and emergency physicians disagree about the utility of thrombolysis in acute ischaemic stroke. They love it, probably because of its …
JC: Kicking against the prick: Systematic Review of stroke thrombolysis Read More »
JC: Platelets for Intracranial Haemorrhage. St.Emlyn’s
The management of stroke is one of those topics that attracts a great deal of controversy in the #FOAMed world, and with good reason. The questions around the use of …
JC: Platelets for Intracranial Haemorrhage. St.Emlyn’s Read More »
JC: Intra-arterial treatment for Stroke
Here at St.Emlyn’s the whole team loves a good stroke trial as they always throw up controversies and concerns about methods, outcomes and our absolute favourite ‘statistics’. That said, although …
Dystonia in the Emergency Department. St Emlyn’s
I’m sure we’ve all seen cases like this. A 25 year old lady walks in to the ED complaining of a swollen tongue. She can’t really talk, seems a bit …
Dystonia in the Emergency Department. St Emlyn’s Read More »
JC: Time is brain…., calling #FOAMagitators. St.Emlyn’s
Streamlining of prehospital stroke management: the golden hour. If you have been happily playing with #FOAM for the last year or two then you must have come across the many …
JC: Time is brain…., calling #FOAMagitators. St.Emlyn’s Read More »
JC: IST-3
So…. We have just covered the following paper in our journal club at Manchester Royal Infirmary. http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(12)60768-5/abstract The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within …